跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
HEMOSATE ULTRA HS2150
Authorized
STANDARD
HEMOSATE ULTRA HS2150
chief medical supplies ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7008a5423b1c6bb7
Company
chief medical supplies ltd
Type
Standard
Approval Details
Approval Id
7008a5423b1c6bb7
Drug Approval Canada Name
HEMOSATE ULTRA HS2150
Product Name
HEMOSATE ULTRA HS2150
Status
Marketed
Status Date
2021-01-15
Original Market Date
2020-03-04
Din
02413957
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Haemodialysis
Schedule
Ethical
Ahfs
40:34.00*
Atc Original
B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name
b 05 za
Aig Number
0752576007
Company Name
chief medical supplies ltd
Company Address
411 19th St Se, Calgary, Alberta, Canada, T2E 6J7
Active Ingredients
CALCIUM CHLORIDE
7.47 G / L
CITRIC ACID
6.91 G / L
MAGNESIUM CHLORIDE
2.14 G / L
DEXTROSE
49.5 G / L
POTASSIUM CHLORIDE
6.71 G / L
SODIUM ACETATE
1.11 G / L
SODIUM CHLORIDE
263 G / L
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7008a5423b1c6bb7
Type
Standard
Back to Health Canada Approvals
HEMOSATE ULTRA HS2150 - Health Canada Drug Approval Details